• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

The MR-INFORM trial: fewer patients undergo revascularization when coronary perfusion is assessed with MRI compared to invasive angiography

byDayton McMillan
June 28, 2019
in Chronic Disease
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In patients with stable angina and multiple cardiac risk factors, those undergoing myocardial-perfusion cardiovascular magnetic resonance imaging (MRI) compared to invasive angiography and measurement of fractional flow reserve (FFR) underwent fewer coronary revascularization procedures.

2. Patients in the MRI group experienced major adverse cardiac events at a rate non-inferior to the FFR group.

Evidence Rating Level: 1 (Excellent)  

Study Rundown: Patients with stable angina are treated to reduce the likelihood of adverse cardiac events. Initial management is focused on risk factor reduction or medication use, but if significant coronary perfusion deficits are found revascularization procedures are recommended. Determination of perfusion deficits can be performed using invasive FFR methods or noninvasive MRI techniques, though major studies are lacking comparing the outcomes of patients evaluated by these methods. The Myocardial Perfusion CMR versus Angiography and FFR to Guide the Management of Patients with Stable Coronary Artery Disease (MR-INFORM) trial randomized patients to MRI or FFR groups and found fewer patients in the MRI group underwent coronary revascularization. The composite adverse event outcome of death or other major cardiac events occurring over 1-year following MRI or FFR occurred at a similar rate in both groups.

Strengths of this study include its randomized design, large study size, and evaluation of multiple secondary outcomes, while it is limited by its follow-up extending out to only 1 year.

Click to read the study in NEJM

Relevant Reading: Diagnostic accuracy of stress myocardial perfusion imaging compared to invasive coronary angiography with fractional flow reserve meta-analysis

RELATED REPORTS

Complete revascularization guided by fractional flow reserve not superior to angiography

#VisualAbstract: Long-term Outcomes Associated With Total Arterial Revascularization vs Non–Total Arterial Revascularization

Long-Term Outcomes Associated With Total Arterial Revascularization vs Non-Total Arterial Revascularization

In-Depth [randomized controlled trial]: This international, unblinded, randomized controlled trial enrolled patients between 2010 and 2015. Eligible patients were adults with angina symptoms who had either two or more cardiovascular risk factors or had a positive exercise stress test. Patients with cardiac arrythmias, contraindications to an adenosine MRI, were in heart failure, had a low estimated glomerular filtration rate, had a prior coronary artery bypass graft, or recent cardiac stent were excluded. Randomization into an MRI (n=454) or FFR (n=464) group was done on a 1:1 basis. MRI was performed with a 1.5 Tesla scanner, and recommendation for revascularization for MRI and FFR was done using standard guidelines. In total, 40.5% and 45.9% of patients in the MRI and FFR groups, respectfully, met criteria to recommend revascularization (P=0.11). Patients who underwent index revascularization was lower in the MRI group (162 [35.7%] vs. 209 [45.0%], P=0.005). At 1-year follow-up, the primary safety outcome of a major cardiac adverse event occurred in 3.6% and 3.7% of MRI and FFR patients, respectfully (risk difference, −0.2 percentage points; 95% confidence interval [CI], −2.7 to 2.4; noninferiority margin, 6 percentage points). There was not difference in time-to-first-event between patients in the MRI and FFR groups. Eight revascularization procedures not performed per-protocol based on recommendations occurred in the MRI and FFR groups. Serious adverse events related to perfusion assessment occurred in similar numbers for each group.

Image: PD

©2019 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc

Tags: Cardiac Catheterizationcoronary perfusionfractional flow reserve (FFRMRI angiography
Previous Post

Defining airflow obstruction as FEV1:FVC of less than 0.70 optimal compared to other fixed thresholds for COPD

Next Post

Quick Take: Safety and Efficacy of the Addition of Lapatinib to Perioperative Chemotherapy for Resectable HER2-Positive Gastroesophageal Adenocarcinoma

RelatedReports

Drug-coated balloons are noninferior to drug-eluting stents for treatment of small vessel coronary artery disease
Cardiology

Complete revascularization guided by fractional flow reserve not superior to angiography

August 5, 2021
#VisualAbstract: Long-term Outcomes Associated With Total Arterial Revascularization vs Non–Total Arterial Revascularization
StudyGraphics

#VisualAbstract: Long-term Outcomes Associated With Total Arterial Revascularization vs Non–Total Arterial Revascularization

April 10, 2020
Cognitive outcomes in older adults undergoing cardiovascular procedures unclear
Cardiology

Long-Term Outcomes Associated With Total Arterial Revascularization vs Non-Total Arterial Revascularization

February 25, 2020
Cardiology

Quick Take: Identification of patients and plaques vulnerable to future coronary events with near-infrared spectroscopy intravascular ultrasound imaging

October 11, 2019
Next Post
Quick Take: Combined Surgery and Extensive Intraoperative Peritoneal Lavage vs Surgery Alone for Treatment of Locally Advanced Gastric Cancer: The SEIPLUS Randomized Clinical Tria

Quick Take: Safety and Efficacy of the Addition of Lapatinib to Perioperative Chemotherapy for Resectable HER2-Positive Gastroesophageal Adenocarcinoma

Variability in interpretation of breast biopsy slides associated with low verification of atypia and ductal carcinoma in situ

Quick Take: Treatment Outcomes of Immune-Related Cutaneous Adverse Events

Cognitive outcomes in older adults undergoing cardiovascular procedures unclear

Quick Take: Comparison of Outcomes After Transcatheter vs Surgical Aortic Valve Replacement Among Patients at Intermediate Operative Risk With a History of Coronary Artery Bypass Graft Surgery

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Childhood maltreatment may cause mental health problems
  • #VisualAbstract: Hydrochlorothiazide does not impact risk of kidney-stone recurrence
  • Metformin use may decrease risk of osteoarthritis development
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options